Network origin in William T. Andrews first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 20 | |
| Subsidiary | Pharmaceuticals: Major | 16 | |
| Subsidiary | Pharmaceuticals: Major | 16 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to William T. Andrews via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal Compliance Officer | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| Stanford University | College/University | Masters Business Admin Doctorate Degree Graduate Degree Undergraduate Degree | |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| BIOGEN INC. | Pharmaceuticals: Major | General Counsel Compliance Officer Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| INVIVO THERAPEUTICS HOLDINGS CORP. | Biotechnology | Director of Finance/CFO Chairman | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | President Chief Tech/Sci/R&D Officer | |
| University of New Hampshire | College/University | Undergraduate Degree Undergraduate Degree | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Sales & Marketing | |
| University of Massachusetts | College/University | Undergraduate Degree Graduate Degree | |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| University of Pittsburgh | College/University | Undergraduate Degree Undergraduate Degree | |
| STANDARD BIOTOOLS INC. | Medical Specialties | Chairman Corporate Officer/Principal | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Blue Cross & Blue Shield of Massachusetts, Inc.
 Blue Cross & Blue Shield of Massachusetts, Inc. Miscellaneous Commercial ServicesCommercial Services Blue Cross & Blue Shield of Massachusetts, Inc. provides indemnity insurance and medicare extension programs. The firm offers medical and dental plans, pharmacy coverage, vision coverage and health savings accounts. The company was founded in 1937 and is located in Boston, MA. | Miscellaneous Commercial Services | General Counsel Director/Board Member | |
| MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | Chairman General Counsel | |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
Nido Biosciences, Inc.
 Nido Biosciences, Inc. BiotechnologyHealth Technology Nido Biosciences, Inc. focuses on developing small molecule therapeutics for the treatment of neurodegenerative diseases. The company is headquartered in Boston, MA. | Biotechnology | Chairman Chief Operating Officer | |
| Worcester Polytechnic Institute | College/University | Undergraduate Degree Graduate Degree | |
| WINDTREE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| Bentley University | College/University | Undergraduate Degree Graduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| ONCORUS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| Tufts University | College/University | Undergraduate Degree Undergraduate Degree | |
| Boston University | College/University | Graduate Degree Graduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin Doctorate Degree | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Compliance Officer General Counsel | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
leon-nanodrugs GmbH
 leon-nanodrugs GmbH Pharmaceuticals: MajorHealth Technology leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Chairman | |
SpePharm AG
 SpePharm AG Pharmaceuticals: MajorHealth Technology SpePharm AG acquires, registers, and markets medical value medicines for the hospital sector. Its brands include Dantrium IV, Dantrium, Dantamacrin, Lymphoseek and Mugard. The company was founded in 2012 and is headquartered in Luzern, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| TME PHARMA N.V. | Biotechnology | Chairman | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chairman | |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
TVM Life Science Management GmbH
 TVM Life Science Management GmbH Miscellaneous Commercial ServicesCommercial Services Part of TVM Capital GmbH, TVM Life Science Management GmbH provides management services. The company is based in Munich, Germany. The CEO of the German company is Stefan Fischer. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AL-S Pharma AG
 AL-S Pharma AG Pharmaceuticals: MajorHealth Technology AL-S Pharma AG engages in the development and marketing of pharmaceutical products. The company was founded by Michael Salzmann on September 19, 2016 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Chairman | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 36 |
| Germany | 8 |
| Switzerland | 4 |
| Canada | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 15 |
| Commercial Services | 5 |
| Health Services | 2 |
Operational
| Director/Board Member | 197 |
| Corporate Officer/Principal | 128 |
| Independent Dir/Board Member | 60 |
| Undergraduate Degree | 46 |
| Chairman | 42 |
Most connected contacts
| Insiders | |
|---|---|
| Heath Lukatch | 43 |
| Samuel D. Colella | 31 |
| Luc Marengère | 31 |
| Hubert Birner | 27 |
| Marc Beer | 25 |
| C. Merrifield | 24 |
| Anne VanLent | 23 |
| Fred Driscoll | 21 |
| Alan Milinazzo | 20 |
| Scott Canute | 17 |
| Gregory Perry | 16 |
| Donald Stern | 15 |
| Mark Rothera | 14 |
| Elizabeth Kwo | 14 |
| Patrick Mahaffy | 13 |
- Stock Market
- Insiders
- William T. Andrews
- Company connections
